Shubham Pant, MD, MD Anderson Cancer Center
Articles
John L. Marshall, MD, MedStar Georgetown University Hospital;Tanios S. Bekaii-Saab, MD, Mayo Clinic;Shubham Pant, MD, MD Anderson Cancer Center;Jyoti D. Patel, MD, Robert H. Lurie Comprehensive Cancer Center;Luis E. Raez, MD, Memorial Healthcare System;Mark A. Socinski, MD, AdventHealth Cancer Institute
May 21st 2020Read More
Challenges for TRK Fusion–Targeting Agents
John L. Marshall, MD, MedStar Georgetown University Hospital;Tanios S. Bekaii-Saab, MD, Mayo Clinic;Shubham Pant, MD, MD Anderson Cancer Center;Jyoti D. Patel, MD, Robert H. Lurie Comprehensive Cancer Center;Luis E. Raez, MD, Memorial Healthcare System;Mark A. Socinski, MD, AdventHealth Cancer Institute
May 21st 2020Read More
Acquired Resistance in TRK Fusion-Positive Cancers
John L. Marshall, MD, MedStar Georgetown University Hospital;Tanios S. Bekaii-Saab, MD, Mayo Clinic;Shubham Pant, MD, MD Anderson Cancer Center;Jyoti D. Patel, MD, Robert H. Lurie Comprehensive Cancer Center;Luis E. Raez, MD, Memorial Healthcare System;Mark A. Socinski, MD, AdventHealth Cancer Institute
May 21st 2020Read More
Approaching Treatment for TRK Fusion–Positive Cancers
John L. Marshall, MD, MedStar Georgetown University Hospital;Tanios S. Bekaii-Saab, MD, Mayo Clinic;Shubham Pant, MD, MD Anderson Cancer Center;Jyoti D. Patel, MD, Robert H. Lurie Comprehensive Cancer Center;Luis E. Raez, MD, Memorial Healthcare System;Mark A. Socinski, MD, AdventHealth Cancer Institute
May 21st 2020Read More
TRK Inhibitor in GI Cancers: Adverse Effect Profile
John L. Marshall, MD, MedStar Georgetown University Hospital;Tanios S. Bekaii-Saab, MD, Mayo Clinic;Shubham Pant, MD, MD Anderson Cancer Center;Jyoti D. Patel, MD, Robert H. Lurie Comprehensive Cancer Center;Luis E. Raez, MD, Memorial Healthcare System;Mark A. Socinski, MD, AdventHealth Cancer Institute
May 21st 2020Read More
John L. Marshall, MD, MedStar Georgetown University Hospital;Tanios S. Bekaii-Saab, MD, Mayo Clinic;Shubham Pant, MD, MD Anderson Cancer Center;Jyoti D. Patel, MD, Robert H. Lurie Comprehensive Cancer Center;Luis E. Raez, MD, Memorial Healthcare System;Mark A. Socinski, MD, AdventHealth Cancer Institute
May 21st 2020Read More
Early Development of TRK Inhibitors
John L. Marshall, MD, MedStar Georgetown University Hospital;Tanios S. Bekaii-Saab, MD, Mayo Clinic;Shubham Pant, MD, MD Anderson Cancer Center;Jyoti D. Patel, MD, Robert H. Lurie Comprehensive Cancer Center;Luis E. Raez, MD, Memorial Healthcare System;Mark A. Socinski, MD, AdventHealth Cancer Institute
May 21st 2020Read More
Advice for Interpreting NGS Reports
John L. Marshall, MD, MedStar Georgetown University Hospital;Tanios S. Bekaii-Saab, MD, Mayo Clinic;Shubham Pant, MD, MD Anderson Cancer Center;Jyoti D. Patel, MD, Robert H. Lurie Comprehensive Cancer Center;Luis E. Raez, MD, Memorial Healthcare System;Mark A. Socinski, MD, AdventHealth Cancer Institute
May 21st 2020Read More
Driver Mutations in NTRK Fusion-Positive Cancers
John L. Marshall, MD, MedStar Georgetown University Hospital;Tanios S. Bekaii-Saab, MD, Mayo Clinic;Shubham Pant, MD, MD Anderson Cancer Center;Jyoti D. Patel, MD, Robert H. Lurie Comprehensive Cancer Center;Luis E. Raez, MD, Memorial Healthcare System;Mark A. Socinski, MD, AdventHealth Cancer Institute
May 21st 2020Read More
Genomic Testing for NTRK Fusions in Lung and GI Cancers
John L. Marshall, MD, MedStar Georgetown University Hospital;Tanios S. Bekaii-Saab, MD, Mayo Clinic;Shubham Pant, MD, MD Anderson Cancer Center;Jyoti D. Patel, MD, Robert H. Lurie Comprehensive Cancer Center;Luis E. Raez, MD, Memorial Healthcare System;Mark A. Socinski, MD, AdventHealth Cancer Institute
May 21st 2020Read More
Approaching Genomic Testing for NTRK Fusions
John L. Marshall, MD, MedStar Georgetown University Hospital;Tanios S. Bekaii-Saab, MD, Mayo Clinic;Shubham Pant, MD, MD Anderson Cancer Center;Jyoti D. Patel, MD, Robert H. Lurie Comprehensive Cancer Center;Luis E. Raez, MD, Memorial Healthcare System;Mark A. Socinski, MD, AdventHealth Cancer Institute
May 21st 2020Read More
Using Molecular Testing in GI Cancers
John L. Marshall, MD, MedStar Georgetown University Hospital;Tanios S. Bekaii-Saab, MD, Mayo Clinic;Shubham Pant, MD, MD Anderson Cancer Center;Jyoti D. Patel, MD, Robert H. Lurie Comprehensive Cancer Center;Luis E. Raez, MD, Memorial Healthcare System;Mark A. Socinski, MD, AdventHealth Cancer Institute
May 21st 2020Read More
Evolution of NGS Testing in Lung Cancers
John L. Marshall, MD, MedStar Georgetown University Hospital;Tanios S. Bekaii-Saab, MD, Mayo Clinic;Shubham Pant, MD, MD Anderson Cancer Center;Jyoti D. Patel, MD, Robert H. Lurie Comprehensive Cancer Center;Luis E. Raez, MD, Memorial Healthcare System;Mark A. Socinski, MD, AdventHealth Cancer Institute
May 21st 2020Read More
Variants of NTRK Fusions in Solid Tumors
John L. Marshall, MD, MedStar Georgetown University Hospital;Tanios S. Bekaii-Saab, MD, Mayo Clinic;Shubham Pant, MD, MD Anderson Cancer Center;Jyoti D. Patel, MD, Robert H. Lurie Comprehensive Cancer Center;Luis E. Raez, MD, Memorial Healthcare System;Mark A. Socinski, MD, AdventHealth Cancer Institute
May 21st 2020Read More
John L. Marshall, MD, MedStar Georgetown University Hospital;Tanios S. Bekaii-Saab, MD, Mayo Clinic;Shubham Pant, MD, MD Anderson Cancer Center;Jyoti D. Patel, MD, Robert H. Lurie Comprehensive Cancer Center;Luis E. Raez, MD, Memorial Healthcare System;Mark A. Socinski, MD, AdventHealth Cancer Institute
May 21st 2020Read More
Latest Updated Articles
Published: July 9th 2024 | Updated: July 10th 2024
Dr Rafiq on Novel Strategies for CAR T-Cell Engineering in Solid Tumors
Published: June 2nd 2024 | Updated: June 3rd 2024
Perioperative Chemotherapy Prolongs OS vs Neoadjuvant Chemoradiation in Esophageal Cancer
Published: July 25th 2024 | Updated: July 27th 2024
Dr Rotow on the Impact of Biomarker Testing on NSCLC Treatment Outcomes
Published: July 25th 2024 | Updated: July 27th 2024
Dr Sabari on Barriers to Biomarker Testing in NSCLC
Published: July 18th 2024 | Updated: July 27th 2024
Treatment Considerations and Patient Selection for CAR T-cell Therapy in R/R ALL
Published: July 18th 2024 | Updated: July 27th 2024
Expert Insights on ZUMA-3 Data Updates: 4-Year Follow-up and Real World Data
